104 related articles for article (PubMed ID: 30477242)
21. Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study.
Fernández A; Salgado M; García A; Buxò E; Vera R; Adeva J; Jiménez-Fonseca P; Quintero G; Llorca C; Cañabate M; López LJ; Muñoz A; Ramírez P; González P; López C; Reboredo M; Gallardo E; Sanchez-Cánovas M; Gallego J; Guillén C; Ruiz-Miravet N; Navarro-Pérez V; De la Cámara J; Alés-Díaz I; Pazo-Cid RA; Carmona-Bayonas A
BMC Cancer; 2018 Nov; 18(1):1185. PubMed ID: 30497432
[TBL] [Abstract][Full Text] [Related]
22. Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2.
Macarulla T; Pazo-Cid R; Guillén-Ponce C; López R; Vera R; Reboredo M; Muñoz Martin A; Rivera F; Díaz Beveridge R; La Casta A; Martín Valadés J; Martínez-Galán J; Ales I; Sastre J; Perea S; Hidalgo M
J Clin Oncol; 2019 Jan; 37(3):230-238. PubMed ID: 30523758
[TBL] [Abstract][Full Text] [Related]
23. Outcomes and Characteristics of Patients Receiving Second-line Therapy for Advanced Pancreatic Cancer.
Tsang ES; Wong HL; Wang Y; Renouf DJ; Cheung WY; Lim HJ; Gill S; Loree JM; Kennecke HF
Am J Clin Oncol; 2019 Feb; 42(2):196-201. PubMed ID: 30499841
[TBL] [Abstract][Full Text] [Related]
24. EpCAM
de Wit S; Manicone M; Rossi E; Lampignano R; Yang L; Zill B; Rengel-Puertas A; Ouhlen M; Crespo M; Berghuis AMS; Andree KC; Vidotto R; Trapp EK; Tzschaschel M; Colomba E; Fowler G; Flohr P; Rescigno P; Fontes MS; Zamarchi R; Fehm T; Neubauer H; Rack B; Alunni-Fabbroni M; Farace F; De Bono J; IJzerman MJ; Terstappen LWMM
Oncotarget; 2018 Nov; 9(86):35705-35716. PubMed ID: 30479699
[TBL] [Abstract][Full Text] [Related]
25. [Circulating tumor cells in pancreatic cancer : Results of morphological and molecular analyses and comparisons with the primary tumor].
Timme-Bronsert S; Bronsert P; Werner M; Kulemann B; Höppner J
Pathologe; 2018 Dec; 39(Suppl 2):311-314. PubMed ID: 30483865
[TBL] [Abstract][Full Text] [Related]
26. The 150 most important questions in cancer research and clinical oncology series: questions 94-101 : Edited by Cancer Communications.
Cancer Communications
Cancer Commun (Lond); 2018 Nov; 38(1):69. PubMed ID: 30477575
[TBL] [Abstract][Full Text] [Related]
27. Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer.
Ko SW; Yoon SB
World J Gastrointest Oncol; 2023 Apr; 15(4):632-643. PubMed ID: 37123055
[TBL] [Abstract][Full Text] [Related]
28. Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response.
Braun R; Lapshyna O; Watzelt J; Drenckhan M; Künstner A; Färber B; Hael AAM; Bolm L; Honselmann KC; Konukiewitz B; Castven D; Spielmann M; Gorantla SP; Busch H; Marquardt JU; Keck T; Wellner UF; Ungefroren H
Cells; 2023 Feb; 12(4):. PubMed ID: 36831254
[TBL] [Abstract][Full Text] [Related]
29. ChemoSensitivity Assay Guided Metronomic Chemotherapy Is Safe and Effective for Treating Advanced Pancreatic Cancer.
Isacoff WH; Cooper B; Bartlett A; McCarthy B; Yu KH
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740571
[TBL] [Abstract][Full Text] [Related]
30. Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and Opportunities.
Chakrabarti S; Kamgar M; Mahipal A
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681565
[TBL] [Abstract][Full Text] [Related]
31. Analysis of capecitabine metabolites in conjunction with digital autoradiography in a murine model of pancreatic cancer suggests extensive drug penetration through the tumor.
Russell J; Fanchon L; Alwaseem H; Molina H; O'Donoghue I; Bahr A; de Stanchina E; Pillarsetty N; Humm JL
Pharmacol Res Perspect; 2022 Apr; 10(2):e00898. PubMed ID: 35257504
[TBL] [Abstract][Full Text] [Related]
32. Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells.
Yeo D; Bastian A; Strauss H; Saxena P; Grimison P; Rasko JEJ
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163592
[TBL] [Abstract][Full Text] [Related]
33. Consequences of Mutations and Abnormal Expression of SMAD4 in Tumors and T Cells.
Wan R; Feng J; Tang L
Onco Targets Ther; 2021; 14():2531-2540. PubMed ID: 33888990
[TBL] [Abstract][Full Text] [Related]
34. Pancreas cancer: Therapeutic trials in metastatic disease.
Smithy JW; O'Reilly EM
J Surg Oncol; 2021 May; 123(6):1475-1488. PubMed ID: 33831245
[TBL] [Abstract][Full Text] [Related]
35. Predicting Gemcitabine Delivery by
Russell J; Grkovski M; O'Donoghue IJ; Kalidindi TM; Pillarsetty N; Burnazi EM; Kulick A; Bahr A; Chang Q; LeKaye HC; de Stanchina E; Yu KH; Humm JL
J Nucl Med; 2021 Feb; 62(2):195-200. PubMed ID: 32646874
[No Abstract] [Full Text] [Related]
36. The propensity of invasive circulating tumor cells (iCTCs) in metastatic progression and therapeutic responsiveness.
Dong H; Tulley S; Zhao Q; Cho L; Chen D; Pearl ML; Chen WT
Cancer Med; 2019 Jul; 8(8):3864-3874. PubMed ID: 31115187
[TBL] [Abstract][Full Text] [Related]
37. Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma.
Yu KH; Ricigliano M; McCarthy B; Chou JF; Capanu M; Cooper B; Bartlett A; Covington C; Lowery MA; O'Reilly EM
Cancers (Basel); 2018 Nov; 10(12):. PubMed ID: 30477242
[TBL] [Abstract][Full Text] [Related]
38. Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer.
Yu KH; Park J; Mittal A; Abou-Alfa GK; El Dika I; Epstein AS; Ilson DH; Kelsen DP; Ku GY; Li J; Park W; Varghese AM; Chou JF; Capanu M; Cooper B; Bartlett A; McCarthy D; Sangar V; McCarthy B; O'Reilly EM
Cancer; 2022 Aug; 128(15):2958-2966. PubMed ID: 35647938
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancer.
Yu KH; Ricigliano M; Hidalgo M; Abou-Alfa GK; Lowery MA; Saltz LB; Crotty JF; Gary K; Cooper B; Lapidus R; Sadowska M; O'Reilly EM
Clin Cancer Res; 2014 Oct; 20(20):5281-9. PubMed ID: 25107917
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
